-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KfZT4ZvFCScokqANlr68P9WG80yhWVYUFk5s+LJhQ9uGGrkYVAZLyztgjULFbVCt oEmFxQ0BCWH8TD7aSh+cOw== 0000950129-03-002835.txt : 20030516 0000950129-03-002835.hdr.sgml : 20030516 20030516143154 ACCESSION NUMBER: 0000950129-03-002835 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030516 ITEM INFORMATION: Other events FILED AS OF DATE: 20030516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENCYSIVE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000887023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133532643 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-20117 FILM NUMBER: 03708183 BUSINESS ADDRESS: STREET 1: 6700 WEST LOOP SOUTH STREET 2: 4TH FLOOR CITY: BELLAIRE STATE: TX ZIP: 77401 BUSINESS PHONE: 7137968822 FORMER COMPANY: FORMER CONFORMED NAME: TEXAS BIOTECHNOLOGY CORP /DE/ DATE OF NAME CHANGE: 19930328 8-K 1 h06129e8vk.txt ENCYSIVE PHARMACEUTICALS INC.- MAY 16, 2003 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report: (Date of earliest event reported): May 16, 2003 ENCYSIVE PHARMACEUTICALS INC. (Exact name of registrant as specified in its charter) DELAWARE 0-20117 13-3532643 (State of Incorporation) (Commission File Number) (IRS Employer Identification No.) 6700 WEST LOOP SOUTH, 4TH FLOOR BELLAIRE, TEXAS 77401 (Address of Registrant's principal executive offices) (713) 796-8822 (Registrant's telephone number, including area code) TEXAS BIOTECHNOLOGY CORPORATION 7000 FANNIN, 20TH FLOOR HOUSTON, TEXAS 77030 (Former name or former address, if changed since last report) ITEM 5. OTHER EVENTS AND REQUIRED FD DISCLOSURE Effective May 16, 2003, pursuant to a vote of the stockholders at the registrant's annual meeting held on May 16, 2003, the registrant changed its name from "Texas Biotechnology Corporation" to "Encysive Pharmaceuticals Inc." The new address for the registrant's principal executive offices was also changed to 6700 West Loop South, 4th Floor, Bellaire, Texas 77401; phone number: (713) 796-8822. In connection with the name change, effective May 19, 2003, the registrant's ticker symbol on the The Nasdaq Stock Market, Inc. will be changed from "TXBI" to "ENCY," and the registrant's Internet website address will be changed from "www.tbc.com" to "www.encysive.com." [SIGNATURE PAGE FOLLOWS] SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date May 16, 2003 ENCYSIVE PHARMACEUTICALS INC. /s/ Stephen L. Mueller ------------------------------------------- Stephen L. Mueller Vice-President, Finance and Administration Secretary and Treasurer -----END PRIVACY-ENHANCED MESSAGE-----